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A B S T R A C T
Purpose: The aim of this paper is to compare the experience of stigma by persons with epilepsy in
Sweden and Iran.
Method: An adapted version of the Internalized Stigma of Mental Illness Scale was completed by 130
persons with epilepsy in Tehran and 93 patients at a neurology clinic in Sweden.
Results: The Swedish subjects reported a signiﬁcantly lower level of experienced stigmatization than the
Iranian patients, which we think is an effect of a more individualized medical treatment and a longer
experience of health education in the Swedish society.
Conclusion: Improved seizure control, legislative measures and health education are major contributory
factors for stigma reduction in a society as regards epilepsy and probably also other medical conditions.
 2013 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
Contents lists available at SciVerse ScienceDirect
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Epilepsy is one of the most stigmatizing disorders worldwide
and a prototype for a stigmatizing disorder with its dramatic and
often scaring symptoms and signs. As effective treatments have
been developed and the knowledge about the nature of the
disorder has increased in the general population, especially in high
income countries with well developed health care and a general
high level of education, the level of stigma attached to the disorder
has slowly decreased.1 There is still, however, a lack of knowledge
about epilepsy in many persons in Sweden. As many as 83% did not
know what to do if a person gets a generalized seizure and there is
still a lot of stigma attached to epilepsy according to a Swedish
study.2 For example, when ﬁndings from this study were reported
in the biggest national newspaper, they wrote about ‘‘epileptics’’ in
the title of the presentation – as if the person would be his/her
disorder!
Part of the stigma complex is the experience of stigma by the
persons suffering from epilepsy and what has been described as
‘‘internalized stigma’’ – ‘‘the devaluation, shame, secrecy and* Corresponding author at: Department of Psychiatry, Umea University, SE-90187
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self’’.3 Ritsher et al.3 have developed a questionnaire Internalized
Stigma of Mental Illness (ISMI) to study internalized stigma related
to mental disorders, which we found useful also related to
epilepsy. This concept of internalized stigma has also been
discussed by Muhlbaum.4
The aim of the study was to compare the experience of
stigmatization of patients suffering from epilepsy in Iran and
Sweden. Sweden is a modern western welfare state with a well-
educated population and a developed health care system. Iran is a
middle income country with a quite well developed health care
system, but a different socio-cultural milieu as an Islamic state
with strict adherence to Islamic teaching and tradition. Islamic
culture is interesting from the point of view that it might represent
a less stigmatizing cultural milieu because of the possible
interpretation derived from the Holy Quran that, whatever
happens to a person, it might be the will of God and not
necessarily a punishment of God. This implies that persons
suffering from different disorders should be treated with respect
and tolerance.5
We hypothesized that (a) patients from both cultures reﬂect on
stigmatization in terms of similar constructs expressed by a similar
factor structure of questionnaire data; and that (b) the stigmati-
zation experience among Swedish patients is less intensive than
among Iranian patients. The ﬁndings might shed light on the
question of how to reduce stigma because of epilepsy and other
medical disorders.vier Ltd. All rights reserved.
Table 2
Cronbach’s alpha of the factor scores.
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2.1. Sample
130 Iranian persons attending an epilepsy clinic at one of the
general hospitals in Tehran and members of the Epilepsy
association in Tehran constituted the Iranian sample.6 The Swedish
subjects were 100 consecutive outpatients attending the Neurolo-
gy clinic at the University Hospital in Umea˚ during four months,
who were asked to complete the questionnaire on stigma.
Completed questionnaires were returned from 93 patients. Some
socio-demographic data on the patients are presented in Table 1.
The samples do not differ related to gender; but, the Iranian
patients were, on average, signiﬁcantly younger (x2(3) = 23.83;
p < .001) and had more years of education (x2(1) = 17.46; p < .001)
than the Swedish patients.
2.2. Measures
An adapted version of ISMI3was completed by the patients. This
questionnaire was originally developed to assess experienced
stigmatization of patients suffering from mental illness. It consists
of 29 items to be rated based on a 4-point-Likert-type scale
(1 = strongly disagree to 4 = strongly agree) implying that high
scores reﬂect severe stigmatization. The original instrument has
ﬁve a priori theory driven subscales labelled as Alienation,
Stereotype endorsement, Perceived discrimination, Social with-
drawal, and Stigma resistance. ISMI has a strong internal
consistency (a = 0.90) and test-retest reliability (r = 0.92) as
reported by Ritscher et al.3 We adapted the items to epilepsy
for our purpose by replacing ‘‘mental illness’’ with ‘‘epilepsy’’ in the
questionnaire by permission from Dr. Ritsher. This adapted
questionnaire will be called ISEP (Internalized Stigma of Epilepsy)
in the following text.
McGlone et al. made a study in 20097 comparing our scale ISMI
with commonly used Felt Stigma Scale (FSS) scale. They concluded
that ISMI was ‘‘A reliable and valid measure in adults with
Epilepsy’’. They also noted ‘‘an important advantage over the brief
FSS in its multi-dimensionality’’.
In the end of the questionnaire there was an open-ended
question on own experiences of being discriminated because of
their epilepsy.
The questionnaire was translated back and forth from English
into Farsi and Swedish.
2.3. Statistics
Cronbach’s alpha as reliability indicator was calculated based
on the originally proposed factor structure by country. A factor
analysis (principal axis factoring; Promax rotation with Kaiser
normalization) limited to a ﬁve-factor solution was separatelyTable 1
Age and years of education by gender (n/%).
Iran Sweden
Females Males Total Females Males Total
N 61/48.0 66/52.0 127 47/51.6 44/48.4 93
Age categories
25 years 22/36.1 29/43.9 51/40.2 15/31.9 9/20.5 24/25.8
26–40 years 30/49.2 28/42.4 58/45.7 15/31.9 15/34.1 31/33.3
41–64 years 9/14.8 8/12.1 17/13.4 14/29.8 13/29.5 27/29.0
65 years 0 1/1.5 1/0.7 3/6.4 7/15.9 11/11.9
Years of education
12 years 18/30.5 33/51.6 51/40.2 27/58.7 35/83.3 63/71.0
12 years 41/69.5 31/48.4 72/59.8 19/41.3 7/16.7 27/29.0conducted on the data of both samples. To compare the structure in
the data between the samples factor congruence coefﬁcients were
calculated by procrustes rotation method. A congruence coefﬁcient
.80 was interpreted as indicative for factor congruence.8 Factor
congruence coefﬁcients were calculated for the comparison of the
factor structure of the Iranian and the Swedish data with the ‘‘ideal
matrix’’ based on the original subscale structure (with a factor
loading of 1 on the factor the items should belong to and a loading
of 0 on the other factors).
Mean scores were compared between the samples on item-
level by t-test for independent samples. Only signiﬁcant differ-
ences with a t-score  5.00; p  .0001 were evaluated as substan-
tial and are reported.
2.4. Ethics
The studies were approved by the appropriate research Ethics
committees in Tehran and Umea˚ and performed according to the
principles of the Helsinki declaration. The questionnaires were
completed anonymously.
3. Results
Internal consistency in terms of Cronbach’s alpha was accept-
able to good for most of the factors based on the originally
proposed structure of the questionnaire except for the scale
‘Stigma resistance’ in the Iranian sample and for the scale
‘Stereotype endorsement’ in the Swedish sample (Table 2).
Neither the factor structure of the Iranian, nor the structure of
the Swedish data supported factor congruence with the original
subscale structure of the Internalized Stigma of Mental Illness
Scale3 by coefﬁcients above the requested level (Table 3).
Additionally, we could not ﬁnd factor congruence between the
data of our two samples.
Therefore, we decided to compare data on the item-level.
Swedish patients with epilepsy, on average, reported substantial
less stigmatization compared to the Iranian with signiﬁcantly
lower scores on 16 of the 29 items (each with t  5.0; p  .0001).
The biggest difference was found for the item ‘‘People discriminate
against me because I have epilepsy’’ (t = 11.84; p  0001). The
items with signiﬁcant differences were; all items of the subscale
‘‘Discrimination experience’’, ﬁve of the seven items of subscale
‘‘Stereotype endorsement’’, ﬁve of the six items of subscale ‘‘Social
withdrawal’’, and one of the ﬁve items of ‘‘Alienation’’. The Iranian
and the Swedish subjects did not differ on any of the items that
originally were supposed to be indicative for Stigma resistance.Table 3
Factor congruence coefﬁcients.
Factor 1 Factor 2 Factor 3 Factor 4 Factor 5
Sweden versus original .65 .47 .52 .65 .79
Iran versus original .58 .73 .54 .42 .51
Sweden versus Iran .82 .54 .57 .35 .57
Factor 1: discrimination experience; Factor 2: stereotype endorsement; Factor 3:
social withdrawal; Factor 4: alienation and Factor 5: stigma resistance.
Factor 1 Factor 2 Factor 3 Factor 4 Factor 5 Overall
Iranians .80 .77 .83 .83 .54 .92
Swedishs .72 .37 .77 .80 .60 .86
Factor 1: discrimination experience; Factor 2: stereotype endorsement; Factor 3:
social withdrawal; Factor 4: alienation and Factor 5: stigma resistance.
Table 5
10 items with lowest means.
Iran Sweden
6 People with epilepsy shouldn’t get married*** (x = 1.74) 6 People with epilepsy shouldn’t get married*** (x = 1.09)
18 People can tell that I have epilepsy by the way I look*** (x = 1.76) 4 I avoid getting close to people who don’t have epilepsy to avoid rejection**
(x = 1.18)
26 In general, I am able to live my life the way I want to (x = 1.81) 18 People can tell that I have epilepsy by the way I look*** (x = 1.19)
27 I can have a good, fulﬁlling life despite my epilepsy (x = 1.81) 20 I stay away from social situations in order to protect my family or friends
from embarrassment** (x = 1.22)
1 I feel out of place in the world because I have epilepsy (x = 1.82) 19 Because I have epilepsy I need others to make most decisions for me**
(x = 1.23)
10 People with epilepsy cannot live good, rewarding life (x = 1.85) 25 Nobody would be interested in getting close to me because I have epilepsy***
(x = 1.26)
25 Nobody would be interested in getting close to me because I have epilepsy***
(x = 1.87)
9 I don’t socialize much because I don’t want to burden others with my
epilepsy*** (x = 1.27)
5 I am embarrassed or ashamed that I have epilepsy (x = 1.89) 3 People discriminate against me because I have epilepsy** (x = 1.28)
20 I stay away from social situations in order to protect my family or friends
from embarrassment*** (x = .90)
23 I can’t contribute anything to society because I have epilepsy** (x = 1.30)
9 I don’t socialize much because I don’t want to burden others with my
epilepsy*** (x = 1.93)
22 People ignore me or take me less seriously just because I have epilepsy**
(x = 1.30)
** Items with signiﬁcant differences between both samples.
*** Items both, under the last ten items in both samples and signiﬁcant differences between the samples.
Table 4
10 items with highest means.
Iran Sweden
24 Living with epilepsy has made me a tough survivor* (x = 2.73) 14 I feel comfortable being seen in public with a person who is known to have
epilepsy* (x = 2.91)
21 People without epilepsy could not possibly understand me* (x = 2.53) 24 Living with epilepsy has made me a tough survivor* (x = 2.30)
3 People discriminate against me because I have epilepsy** (x = 2.51) 21 People without epilepsy could not possibly understand me* (x = 2.05)
11 I don’t talk about myself much because I don’t want to burden others with
my epilepsy* (x = 2.45)
26 In general, I am able to live my life the way I want to (x = 1.93)
15 People often patronize me, or treat me like a child, just because I have an
epilepsy** (x = 2.40)
11 I don’t talk about myself much because I don’t want to burden others with
my epilepsy* (x = 1.82)
14 I feel comfortable being seen in public with a person who is known to have
epilepsy* (x = 2.36)
17 Having epilepsy has spoiled my life (x = 1.67)
12 Negative stereotypes about epilepsy keep me isolated from the ‘‘normal’’
world (x = 2.29)
27 I can have a good, fulﬁlling life, despite my epilepsy (x = 1.66)
28 Others think I can’t achieve much in life because I have epilepsy** (x = 2.28) 16 I am disappointed in myself for having epilepsy (x = 1.63)
22 People ignore me or take me less seriously just because I have epilepsy**
(x = 2.22)
5 I am embarrassed or ashamed that I have epilepsy (x = 1.59)
19 Because I have epilepsy I need others to make most decisions for me**
(x = 2.18)
29 Stereotypes about epilepsy apply to me (x = 1.59)
* Items under the ﬁrst ten in both samples.
** Items with signiﬁcant differences between both samples.
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had made them ‘‘tough survivors’’, the item with the highest mean
score in both samples. There were another three common items
under the ten items indicating most severe stigmatization.
However, the mean score of ﬁve items in the Iranian data was
signiﬁcantly higher than in the Swedish data (each with t  5.0;
p  .0001) (Table 4).
These ten items originally belonged to the different original
subscales; four to ‘‘Discrimination experience’’, two each to ‘‘Social
withdrawal’’ and ‘‘Stigma resistance’’ and one each to ‘‘Alienation’’
and ‘‘Stereotype endorsement’’ in the Iranian data and four each to
‘‘Alienation’’ and ‘‘Stigma resistance’’ and one each to ‘‘Stereotype
endorsement’’ and ‘‘Social withdrawal’’ in the Swedish data.
The patients from both countries showed the highest disagree-
ment to the item stating that patients with epilepsy should not
marry; but the Swedish disagreed signiﬁcantly more than the
Iranians (Table 5).
Five of the ten items with the lowest mean score were the same
in both samples. However, the scores of these ﬁve and of additional
seven items were signiﬁcantly lower in the Swedish than in the
Iranian data. The ten items with the lowest mean scores were
indicative to the original subscales ‘‘Stereotype endorsement’’
(three items), ‘‘Stigma resistance’’, ‘‘Social withdrawal’’ and‘‘Alienation’’ (two items), and ‘‘Discrimination experience’’ (one
item) for the Iranian sample, whereas these items of the Swedish
originally belonged to subscale ‘‘Discrimination experience’’ and
‘‘Social withdrawal’’ (three items each) and ‘‘Stereotype endorse-
ment’’ (four items).
The Iranian subjects were very active in responding to the open-
ended question. Many expressed a need to hide their disorder and
problems to become employed. In the Swedish sample, comments
were less common and mainly dealt with medical aspects. A few
reported on problems with getting job and a need for providing the
general public with more information about the disorder. Several
patients reported that they had no experience of being discrimi-
nated because of their epilepsy.
4. Discussion
The two samples were both convenience samples. The Iranian
subjects were recruited from a specialized clinic for epilepsy and
members of the Iran epilepsy association indicating a rather well-
treated and well-informed group of persons suffering from
epilepsy. The Swedish sample consists of patients to a specialized
university clinic. Patients who were considered not being able to
respond to the questionnaire because of disabilities (for example,
Table 6
Comparison of subscale means and SD between patients suffering from epilepsy in
Sweden and in Tehran.
Subscales ISEP Iran (N = 130) ISEP Sweden (N = 93)
Alienation 2.06 (0.64) 1.66 (0.68)
Stereotype endorsement 1.96 (0.62) 1.32 (0.35)
Discrimination 2.26 (0.71) 1.33 (0. 05)
Social withdrawal 2.10 (0.69) 1.37 (0.50)
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Swedish sample probably consisted of somewhat more complicat-
ed cases than the general epilepsy population. A small proportion
of seizure free patients or with low seizure frequency is treated by
general practitioners and specialists in internal medicine in the
region. The investigated Iranian patients had the opportunity to
ask questions and get support to ﬁll in the questionnaire by one of
the authors (H.G.) whilst the Swedish sample was asked to ﬁll in
the questionnaire by their own. Overall, we assume that the two
samples are reasonably similar with regard to severity of the
disorder and level of medical care. The differences as regards age
and educational level between the two samples we do not think
have a major impact on the results as our main interest is a global
evaluation of the level of experienced stigma in the two settings.
As regards the questionnaire it is apparent that we did not ﬁnd a
similar factor structure in the two samples and this was not really
expected. The subscales in the original paper were basically theory
driven and the team who developed the scale did not even ﬁnd a
complete congruence with the factors derived in a factor analysis.
The authors conclude that ‘‘it is most parsimonious to conceptual-
ize the ISMI as measuring a single construct’’. We present the
original subscales’ mean scores to be able to compare the results
from Iran and Sweden (Table 6). Based on the original subscales the
level of stigmatization is much lower in the Swedish sample (we
have not used the resistance scale as this is considered less
consistent even by the constructors of the scale) than in the Iranian
sample reﬂecting the above reported ﬁndings on item-level.
The results of the single item analysis as well as the subscales
show a signiﬁcant difference between the two samples; the
Swedish patients reporting less internalized stigma according to
the used instrument than the Iranian sample. This was expected
(hypothesis b) for two main reasons. Even if the health care system
in Tehran is well developed it may be that the patients at the
university neurology clinic in Sweden have a more individualized
treatment and follow-up than the Iranian patients. The Iranian
patients often visit the clinic in groups; and the time devoted to
each individual is much shorter than that available for the Swedish
patients. It is also reasonable to assume that the range of available
antiepileptic drugs in Sweden is wider and more diversiﬁed than in
Iran. Furthermore, the monitoring of the patients at the Swedish
clinic is probably more individualized than that of the Iranian.
Patients with different disorders often are organized in patients’
organizations in Sweden, e.g. an epilepsy organization. This
national organization provides information and support to their
members together with their local societies, activities likely to
reduce stigma. A second main explanation might be the general
high level of education and knowledge in the Swedish societyabout epilepsy. Even if there is still a need for more information to
the general public about epilepsy and how to recognize and treat
the disorder it is reasonable to assume that the Swedish public has
a longer experience of health education than the Iranian. However,
there has not been any special national or regional campaign to
inform about epilepsy in Sweden and to reduce stigma. Interna-
tionally, for example, the WHO has launched special campaigns.9
The experience with different types of anti-stigma campaigns is
that they might have a temporary effect, but in the long run it is
probably more important to raise the general educational level in
the population and make legislative measures.10 The most
important measure, however, is probably to improve the
availability of a high quality medical care including diagnosis,
medical treatment, careful monitoring of the disorder and
education to patients and their families on various aspects of
the disorder. Improved seizure control is of major importance for
quality of life and stigma reduction.10–12 The better integrated
individuals who suffer from epilepsy are in the family and in the
society as a whole, the less stigmatizing this disorder will be.
In conclusion the study reveals a signiﬁcantly lower level of
experienced stigmatization in the Swedish subjects compared to
the Iranian which might be the result of a more individualized
medical treatment and a longer experience of health education in
the Swedish society. The ﬁndings will be of interest when
discussing stigma reduction because of medical disorders in a
society.
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